Marinus Pharmaceuticals
Branford
About Marinus Pharmaceuticals
Marinus Pharmaceuticals focuses on creating therapies aimed at improving the lives of individuals affected by seizure disorders. The company emphasizes innovation through cutting-edge science and collaborates with healthcare professionals to enhance patient care.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $451.9M
- Funding stage: M&A
- Last round: Post-IPO Equity (Nov 2022)
- Ticker: nasdaq:MRNS
- Website: marinuspharma.com
- Phone: 484-253-6792
Industries & Categories
Biopharma, Biotechnology, Health Diagnostics, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/marinus-pharmaceuticals-209230 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.